Welcome, Guest. Please login or register.
February 07, 2023, 07:36:09 am

Login with username, password and session length


Members
Stats
  • Total Posts: 767753
  • Total Topics: 65598
  • Online Today: 186
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 1
Guests: 85
Total: 86

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Broadly Neutralizing Antibodies - Broad in Theory, Narrow in Reality  (Read 395 times)

0 Members and 1 Guest are viewing this topic.

Online Jim Allen

  • Administrator
  • Member
  • Posts: 20,227
  • Twitter @JimAllenDublin
    • HIV Lessons

Aidsmap full writeup: https://www.aidsmap.com/news/nov-2022/do-broadly-neutralising-antibodies-really-have-future-treating-hiv

In Short:

Quote

Do broadly neutralising antibodies really have a future in treating HIV?

Although much research is currently exploring how broadly neutralising antibodies may help prevent, treat, or cure HIV, some scientists suggest that without substantially improving their performance, the antibodies’ future role in treating HIV may be scant.

Dr Laura Waters, chair of the British HIV Association, Dr José Arribas, former chair of the  European AIDS Clinical Society's HIV treatment guidelines panel, and colleagues coauthored the commentary. Specifically, they argue that a lack of clarity surrounding appropriate combinations of antibodies, the need for resistance testing, and poor penetration into anatomical reservoirs conspire to make broadly neutralising antibodies less practical than ART.


The combination of 3BNC117 and 10-1074 has been the most widely tested mixture, according to the authors. In one test, the combination didn’t produce persistent viral undetectability in three of four people who responded to the treatment, but the person who started the study with the lowest viral load (under 1000 copies) maintained a viral load of under 20 copies for over eight weeks. Everyone who participated in this study developed some degree of resistance to one of the two antibodies. In another trial, out of 17 people who received up to seven infusions of the same two antibodies, 13 maintained viral suppression without ART for 20 weeks and some for longer.

In summary, some antibody therapies have been shown to delay viral rebound in the absence of ART, but none have prevented it completely (although one person has maintained undetectable viral loads without ART for four years after taking an antibody treatment). Waters and her colleagues also point to other studies showing that broadly neutralising antibodies have no significant impact on reducing the size of the latent reservoir, which is required to truly eradicate HIV from someone’s body.

Ultimately, the authors conclude that given the current standards of ART, broadly neutralising antibodies are unlikely to be used as a first-line treatment for HIV without eliminating the need to conduct resistance screening and overcoming the barrier of maintaining long-term viral suppression. Because ART effectiveness is so high and rates of virologic failure in people taking it are so low, Waters and her colleagues write that demonstrating superior efficacy in neutralising antibodies would currently be “nigh on impossible.

Laura Waters, Rosa de Miguel-Buckley, Sébastien Poulin, Jose R Arribas, Broadly Neutralizing Antibodies for HIV Treatment: Broad in Theory, Narrow in Reality, Clinical Infectious Diseases, 2022;, ciac835, https://doi.org/10.1093/cid/ciac835
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

 


Terms of Membership for these forums
 

© 2023 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.